Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 146 results for pneumonia

  1. What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs) compared with a standard prophylactic dose for venous thromboembolism (VTE) prophylaxis in young people under 18 years with COVID-19?

    Comparator, Outcome) P: patients 18 years and under who have COVID-19 pneumonia I: treatment-dose LMWH C: standard prophylaxis with LMWH...

  2. Intravenous fluid therapy in adults in hospital (QS66)

    This quality standard covers managing intravenous (IV) fluid therapy safely and effectively for adults in hospital. It describes high-quality care in priority areas for improvement.

  3. Stroke rehabilitation in adults (NG236)

    This guideline covers rehabilitation after stroke for over 16s. It aims to ensure people are assessed for common problems and conditions linked to stroke, and get the care and therapy they need. It includes recommendations on the organisation and delivery of rehabilitation in hospital and the community.

  4. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    16 years and over who have been discharged after treatment for COVID-19 pneumonia I: extended (2 to 6 weeks) pharmacological VTE...

  5. Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)

    This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.

  6. Early mobilisation and optimum positioning of people with acute stroke: How safe and effective is very early mobilisation delivered by appropriately trained healthcare professionals after stroke?

    reduction in complications such as venous thromboembolism and hypostatic pneumonia. There could be benefits for motor and sensory...

  7. Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA640)

    Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for malignant diseases in people for whom a reduced intensity regimen would be suitable.

  8. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Comparator, Outcome) P: patients 16 years and over being treated for COVID-19 pneumonia in hospital or the communitywho have:• no...

  9. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  10. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  11. What community-based interventions are effective and cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  12. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  13. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  14. What is the relative effectiveness and cost effectiveness of the different components of multi-component, community-based oral health improvement programmes?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

  15. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (TA199)

    Evidence-based recommendations on etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) for treating active and progressive psoriatic arthritis in adults.